Latest News


Innovation at the Kolling’s core.

In the heart of the Kolling Institute, a world-renowned research centre, a raft of clinical trials is driving the future of healthcare. “Clinical trials are intrinsic to research,” says Professor James Elliott, Academic Director of the institute. “They help us test something so that we can better inform care for patients with various conditions who come to our hospitals for treatment.” The Kolling .....
Read more

Category: Research Excellence

Practical tool to offer better informed care for people living with dementia.

Our researchers at the Kolling Institute are working to improve the use of medications for dementia with a comprehensive analysis highlighting several concerning trends. The latest data indicates more than 420,000 people are living with dementia in Australia, including more women than men. The condition is the second leading cause of death in Australia. Leading researcher and member of the Kolling’.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

Award raises profile of early career research at the Kolling Institute.

Two of the Kolling Institute’s emerging leaders are gaining attention after receiving the ATA Scientific Encouragement Award. The award, which was launched more than a decade ago, aims to provide young scientists with financial assistance to further their education and attend scientific meetings and conferences. Scientific officer Kevin Winardi from the Kolling’s Lab of Ageing and Pharmacology will.....
Read more

Category: Awards, Neuroscience and Pain Research, Research Excellence

Research driving the development of new implants and improving outcomes.

Our researchers at the Kolling Institute have joined with international collaborators to develop a revolutionary implant for hip replacements. The ceramic implant, designed for hip resurfacing procedures, doesn’t require the long stem used in common hip replacements. This means surgeons are not removing the bone which they would generally remove for a hip replacement. Professor Bill Walter, a leadi.....
Read more

Category: Musculoskeletal Research, World-leading technology

Research to improve postmenopausal women’s bone and muscle health.

Related content Back Pain Research Osteoarthritis Research Musculoskeletal Donate
Read more

Category: Musculoskeletal Research, Neuroscience and Pain Research

Philanthropic funds launch crucial research into little-known cancer .

Generous community support is strengthening our research into oesophageal cancer, lifting hopes of improved treatments for the aggressive and deadly cancer. The Fight for a Cure charity has donated $100,000 towards Dr Colby Stevenson’s research, on top of a $100,000 donation from the Howlett family, in memory of their son Scott who died from the cancer. The Howlett family has welcomed the research .....
Read more

Category: Funding support, Research Excellence

Leading new centre to strengthen cancer research and expertise.

Researchers at the Kolling Institute have welcomed the launch of Australia's premier cancer clinical trials centre on the Royal North Shore Hospital campus. NORTH Sydney Trials and Research Van Norton Poche or NORTH STAR VNP has been made possible by a $20 million gift from the late Kay Van Norton Poche and her husband Greg. The centre is a ground-breaking partnership between Northern Sydney Local .....
Read more

Category: Funding support, New Treatment, Research Excellence

Crucial steps towards gene therapy for debilitating Meniere’s disease.

Our researchers at the Kolling Institute are at the forefront of Meniere’s disease science developing the first humanised model of the disease ahead of gene therapy. The specialised team is led by world-leading Meniere’s disease researcher and neuroscientist Professor Jose Antonio Lopez-Escamez who relocated from Spain to the institute to pursue his ground-breaking work. His talented team of seven .....
Read more

Category: Neuroscience and Pain Research, Research Excellence, World-leading technology

Researchers develop urine test based on kidney cell colour and AI to diagnose chronic kidney disease.

We may soon have a convenient and painless approach to diagnose chronic kidney disease following research by the team from the Kolling Institute’s Renal Research Laboratory. Chronic kidney disease is an emerging global health issue, currently affecting more than 11 per cent of Australians and 13 per cent of the worldwide population. By 2032, it’s estimated up to 125 million people will have the con.....
Read more

Category: Cardiovascular and Renal Research, Research Excellence

Special Research Feature - Year in Review 2023.

Our Kolling Institute Year in Review profiles our innovative and life-changing research across the Kolling Institute. Our researchers are driving investigations into some of the most challenging health conditions from heart and kidney disease to musculoskeletal conditions, chronic pain, cancer and neurodegenerative disorders. Our teams have continued to increase their research impact, while forging.....
Read more

Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, Research Excellence